Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Providence Health & Services—Oregon”

14 pharma patents match "Providence Health & Services—Oregon" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 14
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 14 pharmaceutical patents matching "Providence Health & Services—Oregon" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

14 results for “Providence Health & Services—Oregon” · 30,257 patents in full index Clear search

  1. US 12358968

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Providence Health & Services—Oregon · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12336973

    Cancer therapeutic compositions and methods targeting DNAse1L3

    Providence Health & Services—Oregon · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  3. US 11572541

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Providence Health & Services—Oregon · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  4. US 10925945

    Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof

    Providence Health & Services—Oregon · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  5. US 10597732

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  6. US 10597731

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  7. US 10398778

    Method for enhancing specific immunotherapies in cancer treatment

    Providence Health & Services—Oregon · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted
  8. US 9993543

    Immunogenic compositions comprising silicified virus and methods of use

    Providence Health & Services—Oregon · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  9. US 9920378

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  10. US 9872909

    Method for enhancing specific immunotherapies in cancer treatment

    Providence Health & Services—Oregon · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted
  11. US 9828432

    Cancer treatment and monitoring methods using OX40 agonists

    Providence Health & Services—Oregon · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  12. US 9775891

    Methods and compositions for inducing an immune response to EGFRvIII

    Providence Health & Services—Oregon · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  13. US 9226955

    Allogeneic autophagosome-enriched composition for the treatment of disease

    Providence Health & Services—Oregon · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  14. US 9200057

    Methods and compositions for inducing an immune response to EGFRvIII

    Providence Health & Services—Oregon · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted